JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2001; 38:1622-1627
© 2001 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takano, Y.
Right arrow Articles by Tobis, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takano, Y.
Right arrow Articles by Tobis, J. M.

Optimizing stent expansion with new stent delivery systems

Yuzuru Takano, MD, PhDa, Lawrence A. Yeatman, MD, FACCa, James R. Higgins, MDa, Jesse W. Currier, MD, FACCa, Erick Ascencio, RTa, Kristin A. Kopelson, NPa and Jonathan M. Tobis, MD, FACC*,a

a University of California, Los Angeles Center for Health Sciences, Los Angeles, California, USA



View larger version (31K):

[in a new window]
 
Figure 1 Minimum lumen diameter (MLD) predicted by the manufacturer at the pressure used compared with intravascular ultrasound (IVUS) and quantitative coronary angiography (QCA) measurements within the stent. The MLD measured by either IVUS or QCA was significantly smaller than the manufacturer’s expected values.

 


View larger version (28K):

[in a new window]
 
Figure 2 Minimum stent lumen cross-sectional area (CSA) predicted by the manufacturer and measured directly by intravascular ultrasound (IVUS). The measurement of minimum stent CSA by IVUS was significantly smaller than the manufacturer’s expected stent CSA.

 


View larger version (15K):

[in a new window]
 
Figure 3 Relationship of stent lumen cross-sectional area (CSA) between manufacturer’s stated values and in vivo intravascular ultrasound (IVUS) measurements. The manufacturer’s expected areas were determined from a combination of two kinds of stents (Guidant/Tristar or AVE-Medtronic/S670), four stent sizes (2.5 mm, 3.0 mm, 3.5 mm or 4.0 mm) and two inflation pressures (14 or 16 atm).

 


View larger version (143K):

[in a new window]
 
Figure 4 Stenting a left anterior descending coronary artery lesion. Upper left panel: Baseline angiogram shows a severe stenosis at the trifurcation of a diagonal and large septal branch. Upper right panel: After rotational atherectomy and cutting balloon dilation, a 3.5-mm Tristar stent was deployed at 16 atm. There is no residual stenosis, but the minimum stent diameter was 2.8 mm by quantitative coronary angiography. Lower panel: Intravascular ultrasound (IVUS) imaging just after stenting. Intravascular ultrasound revealed a major and minor diameter of 3.2 mm by 2.4 mm, which was 63% of the manufacturer’s expected stent diameter. The predicted stent area at 16 atm was 11.4 mm2. The actual minimum stent cross-sectional area measured by IVUS was 6.0 mm2, which was 53% of the manufacturer’s expected stent area. MLA = minimum lumen area; MLD = minimum lumen diameter.

 





HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2001 by the American College of Cardiology Foundation.